Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Upregulation of Innate Antiviral Restricting Factor Expression in the Cord Blood and Decidual Tissue of HIV-Infected Mothers

Full text
Pereira, Natalli Zanete [1] ; Cardoso, Elaine Cristina [1] ; da Silva Oliveira, Luanda Mara [1] ; de Lima, Josenilson Feitosa [1] ; Calvielli Castelo Branco, Anna Claudia [1] ; de Souza Aveiro Ruocco, Rosa Maria [2] ; Zugaib, Marcelo [2] ; de Oliveira Filho, Joao Bosco [3] ; da Silva Duarte, Alberto Jose [1] ; Sato, Maria Notomi [1]
Total Authors: 10
[1] Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, LIM 56, Dept Dermatol, Trop Med Inst Sao Paulo, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Hosp Clin, Sao Paulo - Brazil
[3] Med Inst Prof Fernando Figueira IMIP, Dept Pediat, Recife, PE - Brazil
Total Affiliations: 3
Document type: Journal article
Source: PLoS One; v. 8, n. 12 DEC 18 2013.
Web of Science Citations: 9

Programs for the prevention of mother-to-child transmission of HIV have reduced the transmission rate of perinatal HIV infection and have thereby increased the number of HIV-exposed uninfected (HEU) infants. Natural immunity to HIV-1 infection in both mothers and newborns needs to be further explored. In this study, we compared the expression of antiviral restricting factors in HIV-infected pregnant mothers treated with antiretroviral therapy (ART) in pregnancy (n=23) and in cord blood (CB) (n=16), placental tissues (n=10-13) and colostrum (n=5-6) samples and compared them to expression in samples from uninfected (UN) pregnant mothers (n=21). Mononuclear cells (MNCs) were prepared from maternal and CB samples following deliveries by cesarean section. Maternal (decidua) and fetal (chorionic villus) placental tissues were obtained, and colostrum was collected 24 h after delivery. The mRNA and protein expression levels of antiviral factors were then evaluated. We observed a significant increase in the mRNA expression levels of antiviral factors in MNCs from HIV-infected mothers and CB, including the apolipoprotein B mRNA-editing enzyme 3G (A3G), A3F, tripartite motif family-5 alpha (TRIM-5 alpha), TRIM-22, myxovirus resistance protein A (MxA), stimulator of interferon (IFN) genes (STING) and IFN-beta, compared with the levels detected in uninfected (UN) mother-CB pairs. Moreover, A3G transcript and protein levels and alpha-defensin transcript levels were decreased in the decidua of HIV-infected mothers. Decreased TRIM-5 alpha protein levels in the villi and increased STING mRNA expression in both placental tissues were also observed in HIV-infected mothers compared with uninfected (UN) mothers. Additionally, colostrum cells from infected mothers showed increased tetherin and IFN-beta mRNA levels and CXCL9 protein levels. The data presented here indicate that antiviral restricting factor expression can be induced in utero in HIV-infected mothers. Future studies are warranted to determine whether this upregulation of antiviral factors during the perinatal period has a protective effect against HIV-1 infection. (AU)

FAPESP's process: 12/18837-1 - Expression of antiviral factors and endogenous retroviruses in HIV-1 infected mothers and newborns
Grantee:Maria Notomi Sato
Support Opportunities: Regular Research Grants